MedTrace Logo

PERsonalized Mammographic Screening in Norway

NCT07371702 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2026-01-29

No results posted yet for this study

Summary

The aim of this study is to assess attendance among women invited to additional breast imaging because they were identified as having an increased risk of breast cancer at screening. High-risk women were defined in two studies: Study A; women with high mammographic density, representing approximately 3-5% of screened women, and Study B; women with a false-positive screening result. Women in Study A will be offered an additional screening examination with digital breast tomosynthesis immediately within 6 months after the screening examination. Women in Study B will be offered an additional standard digital mammography examination one year after their initial screening.

Conditions

Sponsors & Collaborators

  • Norwegian Cancer Society

    collaborator OTHER

  • University Hospital, Akershus

    collaborator OTHER

  • Oslo University Hospital

    collaborator OTHER

  • Vestre Viken Hospital Trust

    collaborator OTHER

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Eligibility

Min Age
50 Years
Max Age
71 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2028-01-31
Completion
2033-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07371702 on ClinicalTrials.gov